Pfizer Ltd (PFIZER) — Board Meeting | 7 September 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Discontinuation of Minipress XL announced
🔄 What Changed
Discontinuation of Minipress XL

Pfizer Limited announced the discontinuation of Minipress XL effective September 7, 2026, following Pfizer Inc.'s decision to stop manufacturing the drug, and will receive a lump sum payment of USD 13.9 million (~Rs. 131.38 crore) from its US parent.

📄 View Original Announcement (PDF)

About Pfizer Ltd (PFIZER)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹18,359.71 Cr P/E: 25.0 ROE: 17.5% ROCE: 23.8%

View full PFIZER stock details →

📡 Get AI alerts when PFIZER files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track PFIZER — Free

📊 More PFIZER filings

See all PFIZER filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when PFIZER files new disclosures

Track PFIZER filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track PFIZER — Free

Free account · 2 AI queries/day